The novel approach of this peptide represents a significant breakthrough in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide999404.dailyhitblog.com/47675485/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment